comparemela.com

Latest Breaking News On - Society for immunotherapy of cancer - Page 2 : comparemela.com

Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript

Summit Therapeutics Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06.

United statesBob dugganAllen yangBrad caninoBradley caninoManmeet soniMostafa ronaghiCarter gouldDave gancarzMaky zanganehUs national cancer instituteEuropean organization for researchSummit therapeutics incTeam summitAmerican association of cancer researchAmerican society of clinical oncology

Lung Cancer Research Foundation Welcomes New Scientific Advisory Board Members

/PRNewswire/ The Lung Cancer Research Foundation (LCRF) has expanded its Scientific Advisory Board (SAB) by five new members. Led by Katerina Politi, PhD,.

United statesDana farber cancer instituteBaden wübergTaofeekk owonikokoDavid macphersonSheila sullivanAaron hataTaofeek owonikokoRocio sotilloShirish gadgeelShirishm gadgeelHenry ford cancer institute healthUniversity of marylandDana farber harvard cancer center lungCancer researchLung committee

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023

• Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology 65th Annual Meeting • Execution of strategic.

New yorkUnited statesFrance generalNorth carolinaBingc wangPascalyne wilsonArthur strilAllogene alloAnnick schwebigAshleyr robinsonMarc dunoyerPatricia sosa navarroAmerican society of geneTaz holdingsEuropean hematology associationCalyxt inc

Cidara Therapeutics Provides Corporate Update and Reports

SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary.

San diegoUnited statesUnited kingdomVeronica eamesJeffrey steinBrian ritchieSan diego unionSociety for immunotherapy of cancerEuropean unionOncology io annual congressExchange commissionAmerican association for cancer researchOncology annual congressSecurities exchangeCidara therapeutics incLifesci communications

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

SAN DIEGO, April 22, 2024 Cidara Therapeutics, Inc. , a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate immunotherapies designed to save lives.

San diegoUnited statesUnited kingdomJeffrey steinVeronica eamesBrian ritchieAmerican association for cancer researchCidara therapeutics incOncology annual congressSecurities exchangeLifesci communicationsGlobenewswire incSan diego unionSociety for immunotherapy of cancerOncology io annual congressEuropean union

vimarsana © 2020. All Rights Reserved.